AI-driven nanomedicine for cancer theranostics

Nanomedicine's merging with artificial intelligence (AI) is fundamentally changing cancer theranostics through precise creation of multifunctional nanoparticles which can simultaneously diagnose and treat diseases. Traditional cancer treatments today face issues with imprecise delivery and general body toxicity as well as late-stage disease recognition which theranostic nanoplatforms address through precision drug transport and live imaging functions. In this analysis, we examine the existing state and forthcoming developments of AI applications in cancer theranostics through nanoparticles. Our study first examines the three primary classes of theranostic nanomaterials that show clinical significance:…

• NS
  National Science and Technology Council

  Award: NSTC 113-2113-M-038-001
• TM
  Taipei Medical University